Roche
ROG.SW
$243.12
Share price
0.41%
Change (1 day)
-21.73%
Change (1 year)
Categories
Roche (ROG.SW) - Total assets
Total assets on the balance sheet as of December 2023 : $107.60 B
According to Roche's latest financial reports the company's total assets are $107.60 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Roche - Total assets on balance sheet (from 2006 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $107.60 B | 12.76% |
| 2022-12-31 | $95.42 B | -5.56% |
| 2021-12-31 | $101.03 B | 3.41% |
| 2020-12-31 | $97.70 B | 13.9% |
| 2019-12-31 | $85.78 B | 7.46% |
| 2018-12-31 | $79.82 B | 1.37% |
| 2017-12-31 | $78.74 B | 4.42% |
| 2016-12-31 | $75.40 B | -1.66% |
| 2015-12-31 | $76.68 B | 0.35% |
| 2014-12-31 | $76.41 B | 9.05% |
| 2013-12-31 | $70.07 B | -1.33% |
| 2012-12-31 | $71.01 B | 8.18% |
| 2011-12-31 | $65.64 B | 0.53% |
| 2010-12-31 | $65.29 B | -9.43% |
| 2009-12-31 | $72.09 B | -1.18% |
| 2008-12-31 | $72.95 B | 5.39% |
| 2007-12-31 | $69.22 B | 13.18% |
| 2006-12-31 | $61.16 B | 16.31% |
| 2005-12-31 | $52.58 B | 2.62% |
| 2004-12-31 | $51.24 B | 6.53% |
| 2003-12-31 | $48.10 B | -31.39% |
| 2002-12-31 | $70.11 B | -15% |
| 2001-12-31 | $82.48 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 55.72% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | -7.12% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 110.50% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | -31.96% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | -9.71% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 29.94% | 🇫🇷 France |
 Becton Dickinson BDX | $52.27 B | -51.42% | 🇺🇸 USA |
 Merck MRK | $106.67 B | -0.86% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | -30.19% | 🇬🇧 UK |